Wed, Aug 20, 2014, 5:01 AM EDT - U.S. Markets open in 4 hrs 29 mins

Recent

% | $
Quotes you view appear here for quick access.

PharmAthene, Inc. Message Board

  • toobig2failagain toobig2failagain Jun 28, 2013 1:25 PM Flag

    PIP -- A Very Manipulated Stock

    Watching the trading of this stock over the last 6 months, one thing I have noticed is how manipulated the stock is -- either by the Market Makers (primarily Knight Trading) -- or by the hedge funds -- ties to CNBC and Bloomberg. Unlike most biotechs, good news NEVER produces a significant staying rise in the stock price. Most news has been positive to very positive in the last 6 months.... However, every day, with no news, up days are almost ALWAYS down, down days are ALWAYS down, and no movement general market days are almost always up or down by a penny.

    It appears that the hedge funds shorting this stock do not allow this stock to move out of its very small trading range, although this stock is a biotech that should be trading easily to its target price like other stocks with similar market caps and potential. PIP makes over $25 million in revenue per year, loses relatively little money and tightly controls its debt and cash flow. Its own drug is in the latter 2nd stage of development, and will definitely be awarded 1/3 to 2/3 settlement in a smallpox vaccine case it has litigated for several years.

    So with a story like that, why is a stock with a potential of making at least $140 million in a case settlement (over $50 million this year), and with the Sparvax drug potentially going to be approved by the FDA for Anthrax :orphan drug status very soon not trading higher from one day to the next?

    Ask the market maker and CNBC. Crooks need to be prosecuted.

    Sentiment: Strong Buy

 
PIP
2.06-0.05(-2.37%)Aug 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.